ResMed (RMD) Reports In-Line Q4 EPS, Revenues Slightly Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| RESMED, Inc. (NYSE: RMD) | Delayed: 241.47 +14.39 (6.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $227.08 | 52 Week High | $70.90 | |||
| Open | $235.39 | 52 Week Low | $50.77 | |||
| Day High | $242.22 | P/E | 108.28 | |||
| Day Low | $234.11 | EPS | $2.23 | |||
| Volume | 918,718 | |||||
